Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Par Pharmaceutical

Division of Endo International PLC

Latest From Cellectis SA

Finance Watch Public Company Edition: Akcea, Kala Launch IPOs While FOPOs Keep Busy Pace

Kala follows July's first biopharma IPO from Ionis spinout Akcea into the stock market. Amicus, Arena and othera go high with major offerings, while Inovio and Regulus go low. Also, Galena, Neothetics provide updates on their hunts for "strategic alternatives."

Financing Business Strategies

EOS Imaging Appoints New US President And CFO

French ortho medical imaging specialist EOS imaging has made two new senior leadership appointments. Mike Lobinsky joins in a newly created role as US President while Pierre Schwich has been hired as the company's new CFO.

Orthopedics Appointments

CAR-T Companies Hang Onto Novartis' Coat-Tails After Historic FDA Panel Vote

The FDA panel landmark recommendation for Novartis' CTL019 should provide a fillip for the other players in the CAR-T field but the response from the investment community has been lukewarm compared with researchers and patients.

ImmunoOncology Advisory Committees

Cellectis Moves First Off-The-Shelf CAR-T Into US Clinical Trials

UCART123 is behind the initial wave of CAR-T drugs for cancer but could have a big advantage as an allogeneic, or off-the-shelf, option. A Phase I trial is now under way in patients with acute myeloid leukemia.

ImmunoOncology Clinical Trials
See All

Company Information